BRIEF-Vascepa Showed Fall In Atherogenic Lipid, Inflammatory Markers In Statin Treated Patients With Reduced Kidney Function
1 分钟阅读
April 12 (Reuters) - Amarin Corporation PLC:
* VASCEPA SHOWED FALL IN ATHEROGENIC LIPID, INFLAMMATORY MARKERS IN STATIN-TREATED PATIENTS WITH REDUCED KIDNEY FUNCTION, PERSISTENT HIGH TRIGLYCERIDES Source text for Eikon: Further company coverage: